Epidemiologiya i Vaktsinoprofilaktika

Aims & Scope

The "Epidemiology and Vaccinal Prevention" journal aims to improve epidemiological knowledge and public health by publishing high-quality research papers and articles focused on innovative strategies about epidemiology and preventing communicable and non-communicable diseases.

The audience includes, but is not limited to, epidemiologists, researchers, microbiologists, immunologists, physicians, and medical students.

The "Epidemiology and Vaccinal Prevention" journal is particularly interested in knowledge of epidemiology and public health-related studies.

The Journal has special focuses on: 1.

Epidemiology of communicable, parasitic and non-communicable diseases: 2.

Vaccination against communicable, non-communicable and parasitic vaccine-preventable diseases Existing vaccines improvement and development of new ones; Vaccine safety; Immunization of different populations; Raising awareness of vaccination and vaccine hesitancy management; Practical guidance on vaccine use; Expansion of the national preventive vaccination schedule. 3.

Epidemiological characteristics and prevention of high-threat pathogens: Diseases/Agents 4.

Epidemiological safety of medical activity 5.

Epidemiological characteristics and prevention of healthcare-associated infections (HAI): terminology and types of HAI; laboratory diagnostics of infections in medical institutions; HAI prevention as part of the general quality control and medical activity safety system implemented in the Russian public health service.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Pandemic COVID-19. Prevention Measures in the Russian Federation

  Citation: 60

  Authors: N. I., I. N., V. V., T. G., O. Р., N. A.

• Hemorrhagic Fever with Renal Syndrome (History, problems and Research Perspectives)

  Citation: 26

  Authors: E. A., J. K., A. D., N. A., N. M., E. S., A. P., A. A., Yu. V., O. M., V. G., D. V., V. N., V. A., S. E.

• The Coronavirus SARS-Cov-2: the Characteristics of Structural Proteins, Contagiousness, and Possible Immune Collisions

  Citation: 24

  Authors: E. Р.

• Interference of SARS-CoV-2 with other Respiratory Viral Infections agents during Pandemic

  Citation: 23

  Authors: A. A., D. M., K. A., L. S., M. I., T. P., E. I., D. A.

• Characteristics of the Epidemic Situation Associated with Acute Respiratory Viral Infections in the Russian Federation during the Pandemic Spread of COVID-19

  Citation: 21

  Authors: T. A., V. G., E. I., A. V., E. G., A. V., S. V., S. N.

• The Modern Concept of Development of Vaccine Prevention in Russia

  Citation: 20

  Authors: N. I., I. V.

• The incidence of COVID-19 medical workers. The issues of biosafety and occupational risk factors

  Citation: 20

  Authors: T. A., A. A., A. V., S. S.

• Healthcare-Associated Infections: Modern Doctrine of Prophylaxis. Part II. Basic Concept

  Citation: 19

  Authors: E. B., L. P., O. V., V. L., I. V., N. I., V. G.

• Epidemiological and Immunological Efficacy of Health Workers Vaccination against Hepatitis B

  Citation: 19

  Authors: V. G., T. A.

• Immunoprophylaxis of Infectious Diseases in Russia: Condition and Perspective of Improvement

  Citation: 19

  Authors: N. I., I. V.